Ayuda
Ir al contenido

Dialnet


Economics of the Pharmaceutical Industry

  • Autores: Darius Lakdawalla
  • Localización: Journal of economic literature, ISSN 0022-0515, Vol. 56, Nº 2, 2018, págs. 397-449
  • Idioma: inglés
  • Texto completo no disponible (Saber más ...)
  • Resumen
    • The pharmaceutical industry accounts for a substantial chunk of the US economy's research and development investments, which have resulted in significant medical breakthroughs. At the same time, the costs of pharmaceutical products continue to rise, as does pressure to adopt direct or indirect controls on pharmaceutical prices. We review the economics literature on the pharmaceutical industry, focusing particularly on its positive and normative implications for the innovation, pricing, and marketing decisions of pharmaceutical firms. We discuss the major achievements of, and persistent gaps in, the literature, along with lessons for policy.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno